Skip to main content
SpringerLink
Log in

Genetic Studies to Identify Hepatic Fibrosis Genes and SNPs in Human Populations

  • Protocol
Fibrosis Research

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 117))

  • 2983 Accesses

Abstract

Increasing evidence suggests that non-sex-linked genetic factors play a role in determining both susceptibility to, and progression of, liver fibrosis. The elucidation of these factors will have many potential benefits in the management of patients with chronic liver disease. A variety of approaches can be used to look for genetic factors playing a role in liver fibrosis. In the future, genome-wide single nucleotide polymorphism (SNP) scanning of cases and controls may become feasible; however, to date, studies have relied on candidate-gene, case-control, allele-association methodology. This section will focus on the design and interpretation of case-control association studies in liver disease using non-alcoholic fatty liver disease (NAFLD) to illustrate the key issues and potential pitfalls of this approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Poynard, T., Mathurin, P., Lai, C.-L., et al., for the PANFIFBROSIS Group. (2003) A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 38, 257–365.

    Article  PubMed  CAS  Google Scholar 

  2. Bataller, R., North, K. E., and Brenner, D. A. (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37, 493–503.

    Article  PubMed  CAS  Google Scholar 

  3. Montgomery, H. and Dansek, A. H. (2003) In search of genetic precision. Lancet 361, 357.

    Article  Google Scholar 

  4. Lander, E. S. and Schork, N. J. (1994) Genetic dissection of complex traits. Science 265, 2037–2048.

    Article  PubMed  CAS  Google Scholar 

  5. Colhoun, H. M., McKeigue, P. M., and Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865–872.

    Article  PubMed  Google Scholar 

  6. Hugot, J.-P., Chamaillard, M., Zouali, H., et al. (2001) Association of NOD2 leucinerich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603.

    Article  PubMed  CAS  Google Scholar 

  7. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science 273, 156–157.

    Article  Google Scholar 

  8. Speilman, R. S. and Ewens, W. J. (1996) The TDT and other family-based tests for linkage disequlibrium. Am. J. Hum. Genet. 59, 983–989.

    Google Scholar 

  9. Speilman, R. S. and Ewens, W. J. (1998) A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am. J. Hum. Genet. 62, 450–458.

    Article  Google Scholar 

  10. Daly, A. K. and Day, C. P. (2001) Candidate gene case-control association studies: advantages and potential pitfalls. Br. J. Clin. Pharmacol. 52, 489–499.

    Article  PubMed  CAS  Google Scholar 

  11. The International SNP Map Working Group. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933.

    Article  Google Scholar 

  12. Judson, R., Salisbury, B., Schneider, J., Windemuth, A., and Stephens, J. C. (2002) How many SNPs does a genome-wide haplotype map require? Pharmacogenomics 3, 379–391.

    Article  PubMed  CAS  Google Scholar 

  13. Patil, N., Berno, A. J., Hinds, D. A., et al. (2001) Blocks of limited haplotype diversity revealed by high resolution scanning of human chromosome 21. Science 294, 1719–1723.

    Article  PubMed  CAS  Google Scholar 

  14. Daly, M. J., Rioux, J. D., Schaffner, S. F., Hudson, T. J., and Lander, E. S. (2001) High resolution haplotype structure in the human genome. Nat. Genet. 29, 229–232.

    Article  PubMed  CAS  Google Scholar 

  15. Johnson, G. C., Esposito, L., Barrat, B. J., et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet. 29, 233–237.

    Article  PubMed  CAS  Google Scholar 

  16. Partin, J. S., Partin, J. C., Schubert, W. K., and McAdams, A. J. (1974) Liver ultrastructure in abetalipoproteinemia: evolution of micronodular cirrhosis. Gastroenterology 67, 107–118.

    PubMed  CAS  Google Scholar 

  17. Yang, S. Q., Lin, H. Z., Lane, M. D., et al. (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94, 2557–2562.

    Article  PubMed  CAS  Google Scholar 

  18. Hillebrandt, S., Goos, C., Matern, S., and Lammert, F. (2002) Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123, 2041–2051.

    Article  PubMed  CAS  Google Scholar 

  19. Shackel, N. A., Gorrell, M. D., and McCaughan, G. W. (2002) Gene array analysis and the liver. Hepatology 36, 1313–1325.

    PubMed  CAS  Google Scholar 

  20. Justice, M., Noveroske, J. K., Weber, J. S., Zheng, B., and Bradley, A. (1999) Mouse ENU mutagenesis. Hum. Mol. Genet. 8, 1955–1963.

    Article  PubMed  CAS  Google Scholar 

  21. Daly, A. K. (2003) Candidate gene case-control studies. Pharmacogenomics 4, 1–13.

    Article  Google Scholar 

  22. Yee, L. J., Tang, J., Gibson, A. W., Kimberly, R., Van Leeuwen, D. J., and Kaslow, R. A. (2001) Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33, 708–712.

    Article  PubMed  CAS  Google Scholar 

  23. Bonkovsky, H. L., Jawaid, Q., Tortorelli, K., et al. (1999) Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J. Hepatol. 31, 421–429.

    Article  PubMed  CAS  Google Scholar 

  24. Wacholder, S., Rothman, N., and Caporaso, N. (2000) Population stratification in epidemiological studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. 92, 1151–1158.

    Article  PubMed  CAS  Google Scholar 

  25. Pritchard, J. K. and Rosenberg, N. A. (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65, 220–228.

    Article  PubMed  CAS  Google Scholar 

  26. Bacanu, S.-A., Devlin, B., and Roeder, K. (2000) The power of genomic control. Am. J. Hum. Genet. 66, 1933–1944.

    Article  PubMed  CAS  Google Scholar 

  27. Sasieni, P. D. (1997) From genotypes to genes: doubling the sample size. Biometrics 53, 1253–1261.

    Article  PubMed  CAS  Google Scholar 

  28. Erhardt, A., Maschner-Olberg, A., Mellenthin, C., et al. (2003) HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis. J. Hepatol. 38, 335–342.

    Article  PubMed  CAS  Google Scholar 

  29. Tung, B. Y., Emond, M. J., Bronner, M. P., Raaka, S. D., Cotler, S. J., and Kowdley, K. V. (2003) Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology 124, 318–326.

    Article  PubMed  CAS  Google Scholar 

  30. Smith, B. C., Grove, J., Guzail, M. A., et al. (1998) Heterozygosity for hereditary haemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 27, 1695–1699.

    Article  PubMed  CAS  Google Scholar 

  31. Woitas, R. P., Ahlenstie, G., Iwan, A., et al. (2002) Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 122, 1721–1728.

    Article  PubMed  CAS  Google Scholar 

  32. Promrat, K., McDermott, D. H., Gonzalez, C. M., et al. (2003) Association of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124, 352–360.

    Article  PubMed  CAS  Google Scholar 

  33. Day, C. P., Bashir, R., James, O. F. W., et al. (1991) Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol related end-organ damage. Hepatology 14, 798–801.

    Article  PubMed  CAS  Google Scholar 

  34. Valenti, L., Fracanzani, A. L., and Dongiovanni, P. (2002) Tumour necrosis factor a promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122, 274–280.

    Article  PubMed  CAS  Google Scholar 

  35. Thursz, M. (2001) MHC and the viral hepatitides. Quart J. Med. 94, 287–291.

    CAS  Google Scholar 

  36. Pouneh, M., Contos, M. J., Haque, M., et al. (2003) Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37, 1286–1292.

    Article  Google Scholar 

  37. Rosenberg, W. M. C. (2003) Rating fibrosis progression in chronic liver diseases. J. Hepatol. 38, 357–360.

    Article  PubMed  Google Scholar 

  38. Edwards-Smith, C. J., Jonsson, J. R., et al. (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30, 526–530.

    Article  PubMed  CAS  Google Scholar 

  39. Jones, D. E. J., Watt, F. E., Metcalf, J. V., Bassendine, M. F., and James, O. F. W. (1999) Familial primary biliary cirrhosis reassessed: a geographically-based population study. J. Hepatol. 30, 402–407.

    Article  PubMed  CAS  Google Scholar 

  40. Cardon, L. R. and Bell, J. I. (2001) Association studies designs for complex diseases. Nat. Rev. 2, 91–99.

    Article  CAS  Google Scholar 

  41. Ioannidis, J. P. A., Trikalinos, T. A., Ntzani, E. E., and Contopoulos-Ioannidis, D. G. (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361, 567–571.

    Article  PubMed  Google Scholar 

  42. Perneger, T. V. (1998) What’s wrong with Bonferroni adjustments? Br. Med. J. 316, 1235–1237.

    Google Scholar 

  43. Powell, E. E., Edwards-Smith, C. J., Hay, J. L., et al. (2000) Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31, 828–833.

    Article  PubMed  CAS  Google Scholar 

  44. Degoul, F., Sutton, A., Mansouri, A., et al. (2001) Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 120, 1468–1474.

    Article  PubMed  CAS  Google Scholar 

  45. Satsangi, J., Chapman, R. W. G., Haldar, N., et al. (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121, 124–130.

    Article  PubMed  CAS  Google Scholar 

  46. Editorial. (1999) Freely associating. Nat. Genet. 22, 1–2.

    Google Scholar 

  47. Donaldson, P. T. (2002) Genetics in autoimmune hepatitis. Semin. Liver Dis. 22, 353–363.

    Article  PubMed  CAS  Google Scholar 

  48. Donaldson, P. T. and Norris, S. (2002) Evaluation of the role of MHC Class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35, 555–564.

    Article  PubMed  CAS  Google Scholar 

  49. Jones, D. E. J. and Donaldson, P. T. (2003) Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin. Liver Dis. 7, 841–864.

    Article  PubMed  Google Scholar 

  50. Gambaro, G., Anglani, F., and D’Angelo, A. (2000) Association studies of genetic polymorphisms and complex disease. Lancet 355, 308–311.

    Article  PubMed  CAS  Google Scholar 

  51. Egger, M., Davey Smith, G., Schneider, M., and Minder, C. (1997) Bias in metaanalysis detected by a simple graphical test. Br. Med. J. 315, 629–634.

    CAS  Google Scholar 

  52. Borràs, E., Coutelle, C., Rosell, A., et al. (2000) Genetic polymorphism of alcohol dehydrogenase in Europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology 31, 984–989.

    Article  PubMed  Google Scholar 

  53. Stewart, S. F., Leathart, J. B., Chen, Y., et al. (2002) The valine-alanine manganese superoxide dismutase polymorphism is not associated with increased oxidative stress or susceptibility to advanced alcoholic liver disease. Hepatology 36, 1355–1360.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Clinical Medical Sciences (Hepatology), University of Newcastle and Freeman Hospital, Newcastle Upon Tyne, UK

    Christopher Paul Day

Authors
  1. Christopher Paul Day
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Feinberg School of Medicine, Northwestern University, Chicago, IL

    John Varga MD

  2. College of Physicians and Surgeons, Columbia University, New York, NY

    David A. Brenner MD

  3. University of Michigan Medical School, Ann Arbor, MI

    Sem H. Phan MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Day, C.P. (2005). Genetic Studies to Identify Hepatic Fibrosis Genes and SNPs in Human Populations. In: Varga, J., Brenner, D.A., Phan, S.H. (eds) Fibrosis Research. Methods in Molecular Medicine, vol 117. Humana Press. https://doi.org/10.1385/1-59259-940-0:315

Download citation

  • DOI: https://doi.org/10.1385/1-59259-940-0:315

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-479-1

  • Online ISBN: 978-1-59259-940-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation